Navigation Links
Finally, The First Ever Treatment for Drug-Resistant HIV

ding to research results.

"In Phase 3 clinical trials of TMC-114, the majority of patients receiving the drug did very well with relatively few side effects," Mitsuya said. "Those patients showed a significant increase in their CD4 cell counts. Many of those patients have been treated for a year or more and have shown no signs of developing a significant resistance to the drug."

Ghosh is now expanding on his design, making alterations to the original molecule aimed at making even more effective treatments. "The most recent protease inhibitors we created are exceedingly potent," he said. Ghosh's work has opened the door to a new path for antiretroviral therapy.

"Earlier, researchers were unsure of how to deal with drug-resistant viruses," he said. "Problems that arose with treatments developed in the 1990s were disheartening. There was no concept on the horizon. We created a conceptually new class of protease inhibitors to combat drug resistance. That has renewed excitement in antiretroviral treatment and provided a direction for the future." These new protease inhibitors are beneficial for reasons beyond their potency and enduring effectiveness, Ghosh said.

"Because they are synthetic, lab-created materials, they are amenable to cost-effective mass production. Keeping costs down greatly increases the accessibility of the drugs to Third World countries where the epidemic is worst."

The design, synthesis and evaluation of these new protease inhibitors will be detailed in a paper in the Aug. 24 issue of the Journal of Medicinal Chemistry and is currently available on the journal's Web site.

Irene Weber of Georgia State University, Eric Walters of Rosalind Franklin University of Medicine and Mitsuya co-authored the papers with Ghosh. Mitsuya characterized the molecules' effectiveness and Walters and Weber performed the crystallography that provided images of the molecules' structures.
<
'"/>




Page: 1 2 3 4

Related medicine news :

1. Finally, light at the end of the tunnel for those suffering tunnel vision
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
4. First human clone is near
5. First Artificial Heart patient has Major setback
6. First head-to-head trials of once weekly Fosamax and Actonel therapies
7. WHO Declares Vietnam First Country to Control SARS
8. Russia Reports First SARS Case
9. Hope for First New Melanoma Treatment in Decades
10. First global SARS meet opens
11. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Finally The First Ever Treatment for Drug Resistant HIV

(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... By 2016, ... have the ability to engage with customers on a highly personal basis, increasing customer ... miss out on big growth opportunities or lose customers to more nimble competitors. , ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham and ... Sudeep Roy in July 2016. Coming to Austin from Philadelphia, Dr. Roy will ... The twelve-month long training is facilitated annually by the American Academy of Facial Plastic ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives with CareMed Urgent & ... support of National Immunization Awareness Month, which is the month of August. , ... illnesses like the flu, measles, and pneumonia, adults need to get their shots ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthline , a provider of intelligent ... (1) examining consumers’ perspectives on digital health . The survey, which was conducted ... innovations in digital health, level of trust in the security of digital health tools, ...
(Date:7/28/2015)... Jose, CA (PRWEB) , ... July 28, 2015 ... ... services, intelligent gateways, and embedded building blocks for edge devices that enable the ... equipped with 4th generation Intel® Core™ i7/i5 processor to provide exceptional computing power ...
Breaking Medicine News(10 mins):Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3
... Edward G.,Rendell today signed House Bill 1150 into ... for children and young,adults with Autism Spectrum Disorder., ... necessary treatments,for individuals with autism up to age ... services and treatments by building a stronger provider,network ...
... of Rochester Medical Center (URMC) will collaborate with the ... national repository of data that will aid academic and ... In addition to helping researchers understand many cardiac problems, ... to detect drugs that can have dangerous effects on ...
... CME company receives maximum term with commendation, ... notice from the Accreditation Council for Pharmacy Education,(ACPE) ... of continuing pharmacy,education for the maximum term with ... for Pharmacy Education as a,provider of continuing pharmacy ...
... This Summer and ... Throughout the Year, PINELLAS PARK, Fla., July ... and its effects on the skin, many,are not aware that the eyes ... Institute and Transitions Optical found that nearly 80,percent of consumers report knowing ...
... on legislation that would cut $358 million,from the ... 9 Seniors across Texas are,speaking out against ... being considered in the U.S. Senate. The legislation ... Advantage program in Texas,alone and severely cut back ...
... Warranted on Impact of Medicare Modernization Act,(MMA) to ... of,Longer Wait Times for Patients in Rural Locations, ... new study,released today in the July issue of ... patients experienced no major changes in their,access to ...
Cached Medicine News:Health News:Pennsylvania Governor Rendell Signs Bill Ensuring Continuity of Care for Children, Young Adults with Autism 2Health News:URMC, FDA to collaborate on national data repository for heart research 2Health News:URMC, FDA to collaborate on national data repository for heart research 3Health News:ArcMesa Educators Reaccredited as a Provider of Continuing Pharmacy Education 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 3Health News:Texas Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2
(Date:7/28/2015)... , July 21, 2015 Research ... addition of the "Pharmaceutical Industry in China ... and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, ... to their offering. This report ... China but also home ...
(Date:7/28/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Insulin Market Development and Demand Forecast to ... Explore more about Global Human Insulin ...
(Date:7/28/2015)... and LINCOLNSHIRE, Ill. , July 28, ... to leverage business acumen on par with their levels ... of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab ... Better Box™ to deliver a comprehensive and intuitive ecosystem ... With advances in four key areas, Sysmex aims to ...
Breaking Medicine Technology:Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4
... Phase I Clinical Evaluation Anticoagulant Inhibits Clotting Factor IXa; ... Antidote Rapidly Reverses Anticoagulant Effect, ORLANDO, Fla., Nov. ... Ia and Phase Ib dose escalation,studies of the Company,s ... an aptamer-based anticoagulant, RB006,and its matched antidote, RB007, which ...
... population for company,s ... minimally invasive knee implant., MINNEAPOLIS, Nov. 6 ... announced today the,OrthoGlide Medial Knee Implant has been implanted in ... a minimally invasive device intended,to relieve pain caused by moderate ...
Cached Medicine Technology:Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 2Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 3The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: